Macro Group targets EGP 1bn in sales this year

Macro Group for Medical and Pharmaceuticals aims to increase its market share by developing its business volume during the current year, by adding new products to increase its sales, or by acquiring investment opportunities that support the business model.

Ahmed Al-Nayeb, Chairman of Macro Group, said that the company aims to achieve a growth rate of 25% in sales during the current year, after achieving a growth in sales of 33% last year.

He added to Daily News Egypt that the company aims to reach EGP 1bn in sales this year, after its sales exceeded EGP 700m last year.

He added that the company seeks to seize a larger market share in the Egyptian market as its market share currently amounts to about 31% of the pharmaceutical market, which amounts to about 5 billion pounds, according to “Aquavia” research.

He explained that the increase in the market share will be achieved by adding new products to its list of products, which currently number more than 143 products.

He explained that the company is working on adding a product of “disinfectants” during the coming period, as part of its plan to introduce non-refined products in the Egyptian market.

He explained that the company’s products replace imports and compete with imported products in the Egyptian market, with high value and quality, and at balanced prices.

He pointed out that the company combines value and price by modernizing its machines, and is always looking for machines with a high production capacity to increase the quantity and reduce the cost, and has already recently replaced production lines for creams and some liquids in order to increase its production capacity.

He said that the company relies on its own resources to finance expansions, and has a good number of offering proceeds on the Egyptian Exchange.